CN102655879B - 疫苗组合物 - Google Patents

疫苗组合物 Download PDF

Info

Publication number
CN102655879B
CN102655879B CN201080057152.5A CN201080057152A CN102655879B CN 102655879 B CN102655879 B CN 102655879B CN 201080057152 A CN201080057152 A CN 201080057152A CN 102655879 B CN102655879 B CN 102655879B
Authority
CN
China
Prior art keywords
type
antigen
inactivated poliovirus
oil
units
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201080057152.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN102655879A (zh
Inventor
贾达夫·谢瑞克·萨卡拉姆
加伊罗拉·苏尼·贾格迪什普拉萨德
高塔姆·玛尼西·马赫什库马
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Serum Institute of India Pvt Ltd
Original Assignee
Serum Institute of India Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serum Institute of India Pvt Ltd filed Critical Serum Institute of India Pvt Ltd
Publication of CN102655879A publication Critical patent/CN102655879A/zh
Application granted granted Critical
Publication of CN102655879B publication Critical patent/CN102655879B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
CN201080057152.5A 2009-12-16 2010-12-16 疫苗组合物 Active CN102655879B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2911MU2009 2009-12-16
IN2911/MUM/2009 2009-12-16
PCT/IN2010/000814 WO2011074006A2 (en) 2009-12-16 2010-12-16 Vaccine composition

Publications (2)

Publication Number Publication Date
CN102655879A CN102655879A (zh) 2012-09-05
CN102655879B true CN102655879B (zh) 2016-03-09

Family

ID=44167787

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201080057152.5A Active CN102655879B (zh) 2009-12-16 2010-12-16 疫苗组合物

Country Status (3)

Country Link
CN (1) CN102655879B (pt)
BR (1) BR112012014689B1 (pt)
WO (1) WO2011074006A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11793869B2 (en) * 2014-10-07 2023-10-24 Serum Institute Of India Pvt Ltd. Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof
US10485862B2 (en) * 2014-10-07 2019-11-26 Serum Institute Of India Pvt Ltd Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof
CN106290886A (zh) * 2016-07-28 2017-01-04 北京科兴生物制品有限公司 一种检测ⅲ型脊髓灰质炎病毒d抗原含量的方法
CN108387726A (zh) * 2018-01-13 2018-08-10 中国医学科学院医学生物学研究所 脊髓灰质炎病毒ⅰ、ⅱ、ⅲ型d抗原同步快速鉴别、定量检测方法及其检测试剂盒和应用
CN108241058A (zh) * 2018-01-13 2018-07-03 中国医学科学院医学生物学研究所 一种脊髓灰质炎病毒ⅲ型d抗原预包被检测方法及其检测试剂盒和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030092145A1 (en) * 2000-08-24 2003-05-15 Vic Jira Viral vaccine composition, process, and methods of use
GB0405787D0 (en) * 2004-03-15 2004-04-21 Chiron Srl Low dose vaccines
EP1645283A1 (en) * 2004-10-08 2006-04-12 Chiron Behring GmbH & Co. KG Combination vaccine

Also Published As

Publication number Publication date
BR112012014689A2 (pt) 2016-04-05
WO2011074006A2 (en) 2011-06-23
CN102655879A (zh) 2012-09-05
WO2011074006A4 (en) 2012-01-05
WO2011074006A3 (en) 2011-11-17
BR112012014689B1 (pt) 2019-11-12

Similar Documents

Publication Publication Date Title
JP6596008B2 (ja) 液体安定なブタウイルスワクチン
TWI786153B (zh) 具有改善之安定性、增強之免疫原性及降低之反應原性的免疫原性組成物和其製備方法
US11524067B2 (en) Methods of vaccine administration
CN102655879B (zh) 疫苗组合物
BRPI0618359A2 (pt) fabricação de vacinas que contêm antìgeno de superfìcie do vìrus da hepatite b e tensoativo
US20100226937A1 (en) Combination vaccines with 1-hydroxy-2-phenoxyethane preservative
JP2012214515A (ja) 血清群ｃ髄膜炎菌を含む複数ワクチン接種
JP5914512B2 (ja) ヒトワクチンとしての使用に適するジフテリアトキソイドの生成のための動物由来成分を含まない発酵培地
JP5712126B2 (ja) 遅延型追加刺激免疫処置に対する迅速な応答
EP3107571A2 (en) Poultry virus vaccines that are liquid stable
WO2017122635A1 (ja) 固定化ウイルス粒子を含むワクチン
Preston et al. Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvant
CA2894260A1 (en) Conjugates for protecting against diphtheria and/or tetanus
RU2754398C1 (ru) Способ получения четырехвалентной вакцины для профилактики гриппа
AU2021206905A1 (en) Methods of vaccine administration
AU2008272428B2 (en) Adaptation of Pitman Moore strain of rabies virus to Primary chick embryo fibroblast cell cultures
JP3812814B2 (ja) 動物用多価オイルアジュバントワクチン
WO2020043874A1 (en) Conjugated haemophilus influenzae vaccine using bordetella outer membrane vesicle
US20220211837A1 (en) Live attenuated influenza vaccine composition and process for preparation thereof
EA043311B1 (ru) Композиция комбинированной вакцины, содержащая уменьшенную дозу инактивированного полиовируса, и способ её получения
WO2023037387A2 (en) Freeze-dried viral combination vaccine compositions and process for preparation thereof
WO2017167768A1 (en) Novel vaccine composition
US20170340727A1 (en) A Rabies Composition Comprising Pika Adjuvant

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: India, Maharashtra

Patentee after: Serum Institute of India Private Limited Company

Address before: India, Maharashtra

Patentee before: Serum Institute of India Ltd.